Reverse chromosome painting for the identification of marker chromosomes and complex translocations in leukemia

✍ Scribed by Ger Arkesteijn; Esther Jumelet; Anton Hagenbeek; Elisabeth Smit; Rosalyn Slater; Anton Martens

• Publisher: John Wiley and Sons
• Year: 1999
• Tongue: English
• Weight: 316 KB
• Volume: 35
• Category: Article
• ISSN: 0196-4763
• DOI: 10.1002/(sici)1097-0320(19990201)35:2<117::aid-cyto2>3.0.co;2-l

✦ Synopsis

Background: Chromosome banding techniques and in situ hybridization reveal the majority of chromosomal aberrations. However, difficulties remain in cases of highly contracted chromosomes, poor quality of the metaphases or the presence of markers with the involvement of several chromosomes. Here, it is demonstrated that reverse painting can be applied successfully starting with bone marrow cells from primary acute myelocytic leukemias (AML). Methods: This was accomplished by culturing the leukemic cells with a cocktail of various growth factors, which yielded sufficient numbers of cells in cycle to harvest chromosomes for sorting. Aberrant chromosomes were flow-sorted and amplified by degenerate oligonucleotideprimed PCR. The resulting products were labeled by nick-translation and hybridized on normal metaphase spreads. Results: Two patients with marker chromosomes in their leukemia cells were analyzed in detail. The hybridization pattern displayed the composition of the aberrant sorted chromosome. Results were compared with conventional cytogenetic analyses that were performed on material obtained from the same aspirate. The reverse-painting technique enabled identification of aberrations that were not detected by conventional cytogenetic analysis. Conclusions: Primary AML cells can be cultured in vitro, using optimal culture conditions, facilitating the production of high quality flow karyotypes, suitable for sorting of marker chromosomes to produce DOP-PCR derived chromosome painting probes for reverse painting. Valuable additional cytogenetic information can thus be obtained about complex chromosomal rearrangements or structural aberrations that could not be completely resolved by conventional cytogenetic analysis.